UNISON - nivolumab then ipilimumab plus nivolumab in advanced non-clear cell renal cell carcinoma (ANZUP 1602): Part 1-Nivolumab monotherapy.

Gedye, C; Pook, DW; Krieger, LEM; Harris, CA; Goh, JC; Kichenadasse, G; Gurney, H; Underhill, C; Parnis, F; Joshua, AM; Ferguson, T; Roncolato, F; Harrison, ML; Begbie, S; Morris, MF; Hovey, EJ; George, M; Prithviraj, P; Liow, ECH; Davis, ID

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (6):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索